The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy

Y. Rustum Taal: Engels

Paperback

€ 99,00

Afwijkende levertijd: 46-48 werkdagen
The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy

Paperback

€ 99,00

Nieuwe boeken gratis bezorgd t/m 31-12-2021 naar NL*
Altijd de laagste prijs voor nieuwe Nederlandstalige boeken
Verlengde retourtermijn: ruilen of retourneren t/m 10 januari 2022
Koop lokaal, ook online!
Bekijk winkelvoorraad

Although 5-fluorouracil (Fura) is the drug of choice for the treat­ ment of patients with advanced colorectal cancer, this agent has limited effectiveness with a reported response rate of 10-20% and a duration of response of only 6-9 months. The large percentage of treatment failures with this agent has spurred a continuing effort to delineate the mechanism(s) of resistance to Fura and to evaluate approaches that would selectively modulate the therapeutic efficacy of this agent. The therapeutic efficacy of FUra has been attributed to its selec­ tive incorporation into RNA and to its inhibition of thymidylate syn­ thase, leading to potent inhibition of DNA synthesis. Studies of cell lines in vitro and model systems in vivo have demonstrated that although mechanism~sensitivity and resistanc; to Fura are multifactorial, in the presence of citrovorum factor (CF, 5-formyltetrahydrofolate) the site of action of Fura becomes predominantly the pronounced and pro­ longed inhibition of thymidylate synthase. This action is the result of stabilization of the covalent ternary complex between FdUMP, an active metabolite of FUra, 5,10-methylenetetrahydrofolates, and thymidylate synthase. This effect of CF is thus an example of the concept of meta­ bolic modulation.
ISBN
9781468456097
Vorm
Paperback
Uitgever
Springer-Verlag New York Inc.
Druk
1e
Verschenen
01-01-2012
Taal
Engels
Pagina's
336 pp.
Genre
Geneeskunde
Geen recensies beschikbaar.
pro-mbooks2 : libris